Nuclear Medicine-Radiopharmaceuticals Market Report

Japan Nuclear Medicine-Radiopharmaceuticals Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Sep 13, 2019
  • PAGES：150
  • REPORT CODE：GMM203665
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Nuclear Medicine-Radiopharmaceuticals market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Nuclear Medicine-Radiopharmaceuticals market. Detailed analysis of key players, along with key growth strategies adopted by Nuclear Medicine-Radiopharmaceuticals industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Immunomedics, Inc. (US)

    • Mallinckrodt Pharmaceuticals (Ireland)

    • Lantheus Medical Imaging, Inc (US)

    • Peregrine Pharmaceuticals, Inc. (US)

    • Avid Radiopharmaceuticals (US)

    • Advanced Medical Isotope Corporation (US)

    • Alseres Pharmaceuticals, Inc (US)

    • ROTOP Pharmaka GmbH S.p.A (Italy)

    • Bayer HealthCare Medical Care (US)

    • Ion Beam Applications S.A (Belgium)

    • Yantai Dongcheng Pharmaceutical (UK)

    • Siemens Healthcare (US)

    • Curium (India)

    • Triad Isotopes, Inc. (US)

    • Alliance Medical (UK)

    • Nordion, Inc. (Canada)

    • Actinium Pharmaceuticals Inc (US)

    • Positron Corporation (US)

    • Medi-Radiopharma Ltd (Hungary)

    • GE Healthcare Inc (US)


    By Type:

    • Diagnostic Medicine

    • Therapeutic Medicine


    By End-User:

    • SPECT

    • PET

    • Therapeutic


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine-Radiopharmaceuticals Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Medicine from 2014 to 2026

      • 1.3.2 Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Medicine from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of SPECT from 2014 to 2026

      • 1.4.2 Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of PET from 2014 to 2026

      • 1.4.3 Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Nuclear Medicine-Radiopharmaceuticals Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Nuclear Medicine-Radiopharmaceuticals by Major Types

      • 3.4.1 Market Size and Growth Rate of Diagnostic Medicine

      • 3.4.2 Market Size and Growth Rate of Therapeutic Medicine

    4 Segmentation of Nuclear Medicine-Radiopharmaceuticals Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Nuclear Medicine-Radiopharmaceuticals by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Nuclear Medicine-Radiopharmaceuticals in SPECT

      • 4.4.2 Market Size and Growth Rate of Nuclear Medicine-Radiopharmaceuticals in PET

      • 4.4.3 Market Size and Growth Rate of Nuclear Medicine-Radiopharmaceuticals in Therapeutic


    5 Market Analysis by Regions

    • 5.1 Japan Nuclear Medicine-Radiopharmaceuticals Production Analysis by Regions

    • 5.2 Japan Nuclear Medicine-Radiopharmaceuticals Consumption Analysis by Regions


    6 Hokkaido Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 6.1 Hokkaido Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 6.2 Hokkaido Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    7 Tohoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 7.1 Tohoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 7.2 Tohoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    8 Kanto Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 8.1 Kanto Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 8.2 Kanto Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    9 Chubu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 9.1 Chubu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 9.2 Chubu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    10 Kinki Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 10.1 Kinki Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 10.2 Kinki Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    11 Chugoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 11.1 Chugoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 11.2 Chugoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    12 Shikoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 12.1 Shikoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 12.2 Shikoku Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    13 Kyushu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis

    • 13.1 Kyushu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major Types

    • 13.2 Kyushu Nuclear Medicine-Radiopharmaceuticals Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Immunomedics, Inc. (US)

      • 14.1.1 Immunomedics, Inc. (US) Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Mallinckrodt Pharmaceuticals (Ireland)

      • 14.2.1 Mallinckrodt Pharmaceuticals (Ireland) Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Lantheus Medical Imaging, Inc (US)

      • 14.3.1 Lantheus Medical Imaging, Inc (US) Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Peregrine Pharmaceuticals, Inc. (US)

      • 14.4.1 Peregrine Pharmaceuticals, Inc. (US) Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Avid Radiopharmaceuticals (US)

      • 14.5.1 Avid Radiopharmaceuticals (US) Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Advanced Medical Isotope Corporation (US)

      • 14.6.1 Advanced Medical Isotope Corporation (US) Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Alseres Pharmaceuticals, Inc (US)

      • 14.7.1 Alseres Pharmaceuticals, Inc (US) Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 ROTOP Pharmaka GmbH S.p.A (Italy)

      • 14.8.1 ROTOP Pharmaka GmbH S.p.A (Italy) Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Bayer HealthCare Medical Care (US)

      • 14.9.1 Bayer HealthCare Medical Care (US) Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 Ion Beam Applications S.A (Belgium)

      • 14.10.1 Ion Beam Applications S.A (Belgium) Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Yantai Dongcheng Pharmaceutical (UK)

      • 14.11.1 Yantai Dongcheng Pharmaceutical (UK) Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Siemens Healthcare (US)

      • 14.12.1 Siemens Healthcare (US) Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Curium (India)

      • 14.13.1 Curium (India) Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 Triad Isotopes, Inc. (US)

      • 14.14.1 Triad Isotopes, Inc. (US) Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

    • 14.15 Alliance Medical (UK)

      • 14.15.1 Alliance Medical (UK) Company Profile and Recent Development

      • 14.15.2 Market Performance

      • 14.15.3 Product and Service Introduction

    • 14.16 Nordion, Inc. (Canada)

      • 14.16.1 Nordion, Inc. (Canada) Company Profile and Recent Development

      • 14.16.2 Market Performance

      • 14.16.3 Product and Service Introduction

    • 14.17 Actinium Pharmaceuticals Inc (US)

      • 14.17.1 Actinium Pharmaceuticals Inc (US) Company Profile and Recent Development

      • 14.17.2 Market Performance

      • 14.17.3 Product and Service Introduction

    • 14.18 Positron Corporation (US)

      • 14.18.1 Positron Corporation (US) Company Profile and Recent Development

      • 14.18.2 Market Performance

      • 14.18.3 Product and Service Introduction

    • 14.19 Medi-Radiopharma Ltd (Hungary)

      • 14.19.1 Medi-Radiopharma Ltd (Hungary) Company Profile and Recent Development

      • 14.19.2 Market Performance

      • 14.19.3 Product and Service Introduction

    • 14.20 GE Healthcare Inc (US)

      • 14.20.1 GE Healthcare Inc (US) Company Profile and Recent Development

      • 14.20.2 Market Performance

      • 14.20.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 98 Figures and 174 Tables)

     

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Diagnostic Medicine from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Therapeutic Medicine from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of SPECT from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of PET from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Nuclear Medicine-Radiopharmaceuticals Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Nuclear Medicine-Radiopharmaceuticals

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Nuclear Medicine-Radiopharmaceuticals by Different Types from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine-Radiopharmaceuticals by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Diagnostic Medicine

    • Figure Market Size and Growth Rate of Therapeutic Medicine

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Nuclear Medicine-Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Table Consumption Share of Nuclear Medicine-Radiopharmaceuticals by Different End-Users from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of SPECT from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of PET from 2014 to 2026

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • Table Japan Nuclear Medicine-Radiopharmaceuticals Production by Regions

    • Table Japan Nuclear Medicine-Radiopharmaceuticals Production Share by Regions

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Production Share by Regions in 2014

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Production Share by Regions in 2018

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Production Share by Regions in 2026

    • Table Japan Nuclear Medicine-Radiopharmaceuticals Consumption by Regions

    • Table Japan Nuclear Medicine-Radiopharmaceuticals Consumption Share by Regions

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Consumption Share by Regions in 2014

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Consumption Share by Regions in 2018

    • Figure Japan Nuclear Medicine-Radiopharmaceuticals Consumption Share by Regions in 2026

    • Table Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Hokkaido Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Tohoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kanto Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kanto Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kanto Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Chubu Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Chubu Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Chubu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kinki Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kinki Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kinki Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Chugoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Shikoku Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption by Types from 2014 to 2026

    • Table Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2014

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2018

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by Types in 2026

    • Table Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption by End-Users from 2014 to 2026

    • Table Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2014

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2018

    • Figure Kyushu Nuclear Medicine-Radiopharmaceuticals Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Immunomedics, Inc. (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immunomedics, Inc. (US)

    • Figure Sales and Growth Rate Analysis of Immunomedics, Inc. (US)

    • Figure Revenue and Market Share Analysis of Immunomedics, Inc. (US)

    • Table Product and Service Introduction of Immunomedics, Inc. (US)

    • Table Company Profile and Development Status of Mallinckrodt Pharmaceuticals (Ireland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt Pharmaceuticals (Ireland)

    • Figure Sales and Growth Rate Analysis of Mallinckrodt Pharmaceuticals (Ireland)

    • Figure Revenue and Market Share Analysis of Mallinckrodt Pharmaceuticals (Ireland)

    • Table Product and Service Introduction of Mallinckrodt Pharmaceuticals (Ireland)

    • Table Company Profile and Development Status of Lantheus Medical Imaging, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lantheus Medical Imaging, Inc (US)

    • Figure Sales and Growth Rate Analysis of Lantheus Medical Imaging, Inc (US)

    • Figure Revenue and Market Share Analysis of Lantheus Medical Imaging, Inc (US)

    • Table Product and Service Introduction of Lantheus Medical Imaging, Inc (US)

    • Table Company Profile and Development Status of Peregrine Pharmaceuticals, Inc. (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Peregrine Pharmaceuticals, Inc. (US)

    • Figure Sales and Growth Rate Analysis of Peregrine Pharmaceuticals, Inc. (US)

    • Figure Revenue and Market Share Analysis of Peregrine Pharmaceuticals, Inc. (US)

    • Table Product and Service Introduction of Peregrine Pharmaceuticals, Inc. (US)

    • Table Company Profile and Development Status of Avid Radiopharmaceuticals (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Avid Radiopharmaceuticals (US)

    • Figure Sales and Growth Rate Analysis of Avid Radiopharmaceuticals (US)

    • Figure Revenue and Market Share Analysis of Avid Radiopharmaceuticals (US)

    • Table Product and Service Introduction of Avid Radiopharmaceuticals (US)

    • Table Company Profile and Development Status of Advanced Medical Isotope Corporation (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Medical Isotope Corporation (US)

    • Figure Sales and Growth Rate Analysis of Advanced Medical Isotope Corporation (US)

    • Figure Revenue and Market Share Analysis of Advanced Medical Isotope Corporation (US)

    • Table Product and Service Introduction of Advanced Medical Isotope Corporation (US)

    • Table Company Profile and Development Status of Alseres Pharmaceuticals, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alseres Pharmaceuticals, Inc (US)

    • Figure Sales and Growth Rate Analysis of Alseres Pharmaceuticals, Inc (US)

    • Figure Revenue and Market Share Analysis of Alseres Pharmaceuticals, Inc (US)

    • Table Product and Service Introduction of Alseres Pharmaceuticals, Inc (US)

    • Table Company Profile and Development Status of ROTOP Pharmaka GmbH S.p.A (Italy)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ROTOP Pharmaka GmbH S.p.A (Italy)

    • Figure Sales and Growth Rate Analysis of ROTOP Pharmaka GmbH S.p.A (Italy)

    • Figure Revenue and Market Share Analysis of ROTOP Pharmaka GmbH S.p.A (Italy)

    • Table Product and Service Introduction of ROTOP Pharmaka GmbH S.p.A (Italy)

    • Table Company Profile and Development Status of Bayer HealthCare Medical Care (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer HealthCare Medical Care (US)

    • Figure Sales and Growth Rate Analysis of Bayer HealthCare Medical Care (US)

    • Figure Revenue and Market Share Analysis of Bayer HealthCare Medical Care (US)

    • Table Product and Service Introduction of Bayer HealthCare Medical Care (US)

    • Table Company Profile and Development Status of Ion Beam Applications S.A (Belgium)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ion Beam Applications S.A (Belgium)

    • Figure Sales and Growth Rate Analysis of Ion Beam Applications S.A (Belgium)

    • Figure Revenue and Market Share Analysis of Ion Beam Applications S.A (Belgium)

    • Table Product and Service Introduction of Ion Beam Applications S.A (Belgium)

    • Table Company Profile and Development Status of Yantai Dongcheng Pharmaceutical (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yantai Dongcheng Pharmaceutical (UK)

    • Figure Sales and Growth Rate Analysis of Yantai Dongcheng Pharmaceutical (UK)

    • Figure Revenue and Market Share Analysis of Yantai Dongcheng Pharmaceutical (UK)

    • Table Product and Service Introduction of Yantai Dongcheng Pharmaceutical (UK)

    • Table Company Profile and Development Status of Siemens Healthcare (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare (US)

    • Figure Sales and Growth Rate Analysis of Siemens Healthcare (US)

    • Figure Revenue and Market Share Analysis of Siemens Healthcare (US)

    • Table Product and Service Introduction of Siemens Healthcare (US)

    • Table Company Profile and Development Status of Curium (India)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Curium (India)

    • Figure Sales and Growth Rate Analysis of Curium (India)

    • Figure Revenue and Market Share Analysis of Curium (India)

    • Table Product and Service Introduction of Curium (India)

    • Table Company Profile and Development Status of Triad Isotopes, Inc. (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Triad Isotopes, Inc. (US)

    • Figure Sales and Growth Rate Analysis of Triad Isotopes, Inc. (US)

    • Figure Revenue and Market Share Analysis of Triad Isotopes, Inc. (US)

    • Table Product and Service Introduction of Triad Isotopes, Inc. (US)

    • Table Company Profile and Development Status of Alliance Medical (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alliance Medical (UK)

    • Figure Sales and Growth Rate Analysis of Alliance Medical (UK)

    • Figure Revenue and Market Share Analysis of Alliance Medical (UK)

    • Table Product and Service Introduction of Alliance Medical (UK)

    • Table Company Profile and Development Status of Nordion, Inc. (Canada)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion, Inc. (Canada)

    • Figure Sales and Growth Rate Analysis of Nordion, Inc. (Canada)

    • Figure Revenue and Market Share Analysis of Nordion, Inc. (Canada)

    • Table Product and Service Introduction of Nordion, Inc. (Canada)

    • Table Company Profile and Development Status of Actinium Pharmaceuticals Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actinium Pharmaceuticals Inc (US)

    • Figure Sales and Growth Rate Analysis of Actinium Pharmaceuticals Inc (US)

    • Figure Revenue and Market Share Analysis of Actinium Pharmaceuticals Inc (US)

    • Table Product and Service Introduction of Actinium Pharmaceuticals Inc (US)

    • Table Company Profile and Development Status of Positron Corporation (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Positron Corporation (US)

    • Figure Sales and Growth Rate Analysis of Positron Corporation (US)

    • Figure Revenue and Market Share Analysis of Positron Corporation (US)

    • Table Product and Service Introduction of Positron Corporation (US)

    • Table Company Profile and Development Status of Medi-Radiopharma Ltd (Hungary)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medi-Radiopharma Ltd (Hungary)

    • Figure Sales and Growth Rate Analysis of Medi-Radiopharma Ltd (Hungary)

    • Figure Revenue and Market Share Analysis of Medi-Radiopharma Ltd (Hungary)

    • Table Product and Service Introduction of Medi-Radiopharma Ltd (Hungary)

    • Table Company Profile and Development Status of GE Healthcare Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare Inc (US)

    • Figure Sales and Growth Rate Analysis of GE Healthcare Inc (US)

    • Figure Revenue and Market Share Analysis of GE Healthcare Inc (US)

    • Table Product and Service Introduction of GE Healthcare Inc (US)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US